Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability

Epilepsy and Behavior

Volumn 10, Issue 2, 2007, Pages 336-339

  Simister, Robert J ^a,b   Sander, Josemir W ^a,b   Koepp, Matthias J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

Chronic epilepsy; Learning disability; New antiepileptic drugs; Retention rates

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; NEW DRUG; OXCARBAZEPINE; TIAGABINE; TOPIRAMATE; VIGABATRIN;

ADULT; AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG RETENTION; DRUG SUBSTITUTION; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FEMALE; HEADACHE; HUMAN; INFORMATION PROCESSING; LEARNING DISORDER; LICENSING; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MENTAL DISEASE; QUANTITATIVE ANALYSIS; RESIDENTIAL CARE; SEIZURE; SIDE EFFECT; SPEECH; TREATMENT DURATION; TREMOR; UNSTEADINESS; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHRONIC DISEASE; EPILEPSY; FEMALE; HUMANS; LEARNING DISORDERS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES;

EID: 33947264115     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.12.005     Document Type: Article

References (9)

1. Lhatoo S.D., Wong I.C., Polizzi G., and Sander J.W. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia 41 (2000) 1592-1596
2. Wong I.C., Chadwick D.W., Fenwick P.B., Mawer G.E., and Sander J.W. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. Epilepsia 40 (1999) 1439-1445
3. Sander J.W. New antiepileptic drugs in practice: how do they perform in the real world?. Acta Neurol Scand Suppl 181 (2005) 26-29
4. Lhatoo S.D., Wong I.C., and Sander J.W. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy. Epilepsia 41 (2000) 338-341
5. Kellett M.W., Smith D.F., Stockton P.A., and Chadwick D.W. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry 66 (1999) 759-763
6. Krakow K., Walker M., Otoul C., and Sander J.W. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 56 (2001) 1772-1774
7. Kluger G., Berz K., and Holthausen H. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. Eur J Paediatr Neurol 5 (2001) 37-40
8. Bootsma H.P., Coolen F., Aldenkamp A.P., et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 5 (2004) 380-387
9. Depondt C., Yuen A.W., Bell G.S., et al. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J Neurol Neurosurg Psychiatry 77 (2006) 101-103